Eliquis (Apixaban) is a Factor Xa inhibitor, a newer class of anticoagulants that works by blocking a protein involved in blood clotting. The FDA approved Eliquis in 2012 to help reduce the risk of stroke and emobolism in patients diagnosed with non-valvular atrial fibrillation and to prevent deep vein thrombosis after knee or hip replacement surgery. The blood thinner, manufactured by Pfizer and Bristol-Myers Squibb, was promoted as a more convenient and effective drug than Warfarin (Coumadin) and quickly gained blockbuster status.
Blood Thinner Eliquis and Uncontrollable Bleeding
While Eliquis has minimal contraindications with foods or other prescription medications, the drug can cause uncontrolled bleeding, leading to potentially life-threatening complications. This adverse side effect has generated significant concern in the medical community while spawning a wave of litigation. Blood thinner lawsuits concerning Eliquis allege a number of grave injuries — some fatal — including:
- Cerebral hemorrhages
- Gastrointestinal bleeding
- Uncontrolled internal hemorrhages
- Hemorrhagic stroke
- Cardiac bleeds
- Rectal bleeding
Plaintiffs are suing Pfizer and Bristol-Myers Squibb after suffering uncontrollable bleeding events brought on by Eliquis that required hospitalization, costly medical treatments, and in some cases, blood transfusions.
Plaintiffs contend that Eliquis lacked adequate warnings about risk for internal bleeding. The lawsuits also argue that the defendants failed to identify an antidote to bleeding events before introducing the medication.
According to court documents, Pfizer and Bristol Meyers Squibb:
- Negligently promoted Eliquis without thorough pre-market testing
- Concealed dangerous side effects from the public
- Failed to investigate reports of uncontrolled bleeding from Eliquis
- Negligently failed to recommend routine blood monitoring while taking Eliquis
Litigation also contends that Eliquis drug manufacturers not only concealed information about bleeding risks but provided false information to the FDA about the safety of Apixaban.
Eliquis Plaintiff’s Can Receive Compensation
By filing a blood thinner lawsuit, plaintiffs may seek compensation for a variety of losses stemming from their Eliquis injuries, including:
- Lost income
- Medical expenses – past and future
- Pain and suffering
- Emotional distress
- Burial and funeral expenses in cases of wrongful death
Contact a Eliquis lawyer
Showard Law Firm is investigating claims involving Eliquis bleeding injuries and wrongful death. Pharmaceutical makers have a duty to ensure the products they manufacture and distribute are safe and effective for their intended purpose. If there are risks of adverse side effects with their medication, they are obligated to provide sufficient warning or face legal repercussions.
As your local law firm, we meet with every plaintiff, offering compassion and expertise. Call today to set up a free consultation with a member of our team.
Additional Eliquis Resources:
- Prescrire International, Bleeding with Dabigatran, Rivaroxaban, Apixaban. No antidote, and little clinical experience https://www.ncbi.nlm.nih.gov/pubmed/23866358
- HealthDay, Anti-Clotting Drug May Cause Severe Bleeding With No Benefit https://consumer.healthday.com/cardiovascular-health-information-20/heart-stroke-related-stroke-353/anti-clotting-drug-may-cause-severe-bleeding-with-no-benefit-655145.html
- Bristol Meyers Squibb, Eliquis Package Insert https://packageinserts.bms.com/pi/pi_eliquis.pdf